dr. kabir ensbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · kabir a, pourshams a, khoshnia...

14
1 Ali Kabir, MD, MPH PhD Candidate of Epidemiology http://scholar.google.com/citations?user=OhHS5OUAAAAJ CV in brief: 1. Personal History 2. Educational Background: MD, MPH 3. Licensure 4. Positions: Head of Research Department 5. Clinical practice: 6 years 6. Publications a. International journals (PubMed/ISI) : 65 [H-index: 12] b. National journals : 43 c. Persian Books :4 d. Under review/writing Manuscripts : 30 e. Abstracts: 5 7. Poster Presentation: 10 8. Oral Presentation: 8 9. Teaching Experiences: more than 300 workshops 10. Research Interest: Research Methodology, Meta analysis, Hepatology 11. Memberships 12. Other Skills: Expert in SPSS, EPI, STATA and Microsoft Office 13. Additional Courses and Trainings: Stem Cell and Gene Therapy in Clinical Practice 14. Awards: Best Student Researcher of Iran in the field of Clinical Sciences in 2009, Annual 15 th Razi Festival; Tehran, Iran 15. Scientific Reviewer and Arbitration 16. Personal Interests 17. Invitations 18. Referee

Upload: others

Post on 20-Sep-2020

23 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

1

Ali Kabir, MD, MPH PhD Candidate of Epidemiology

http://scholar.google.com/citations?user=OhHS5OUAAAAJ

� CV in brief: 1. Personal History 2. Educational Background: MD, MPH 3. Licensure 4. Positions: Head of Research Department 5. Clinical practice: 6 years 6. Publications

a. International journals (PubMed/ISI): 65 [H-index: 12] b. National journals: 43 c. Persian Books: 4d. Under review/writing Manuscripts: 30 e. Abstracts: 5

7. Poster Presentation: 10 8. Oral Presentation: 8 9. Teaching Experiences: more than 300 workshops 10. Research Interest: Research Methodology, Meta analysis, Hepatology 11. Memberships 12. Other Skills: Expert in SPSS, EPI, STATA and Microsoft Office 13. Additional Courses and Trainings: Stem Cell and Gene Therapy in Clinical Practice 14. Awards: Best Student Researcher of Iran in the field of Clinical Sciences in 2009, Annual

15th Razi Festival; Tehran, Iran 15. Scientific Reviewer and Arbitration 16. Personal Interests 17. Invitations 18. Referee

Page 2: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

2

1. Personal History Date of birth: 19 May 1977 Place of birth: Qom / Iran Sex: Male Marital status: Single Nationality: Iranian Office address: Department of Epidemiology, Faculty of Health, Shahid Beheshti University of Medical Sciences, Evin, Chamran Highway, Tabnak street, Postcode: 19836, Tehran, Iran Office Phone: +98-21-22431993 Office fax: +98-21-44468645 PO Box: 14155-3651 Department: Epidemiology Home address: No. 6, Unit #5, Ramin Dd. end Alley, Mohammadi St., ShahrAra St., Sattarkhan St., Tehran, Iran Phone: +98-21-44411108 Personal E-mail: [email protected]: +98-912-3885570 Language skills: Farsi – English

2. Educational Background a. Medical Doctorate and medical internship (1995-2002) School of Medicine, Iran University of Medical Sciences, Tehran, Iran (total average score: 16.85 from 20) Thesis: Evaluation of the Effect of Islamic Fasting on Lung Volumes and Capacities in the Healthy Persons. Accepted with highest honors (20 from 20) b. Master of Public Health (September 2009- March 2011), School of Public Health, Tehran University of Medical Sciences, Tehran, Iran (total average score: 18.81 from 20) Dissertation: Inequality of diagnosis and treatment of hypertension in Kerman Accepted with highest honors (20 from 20) c. PhD student of Epidemiology (February 2011 – present), School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3. Licensure • Iranian Medical License issued on September 27th 2002 by the Ministry of Health and Medical Education

of Iran. • Passed USMLE step 1 at October 2008 • Passed Polymerase Chain Reaction Course at September 2009 • IELTS Score (Feb 2010): 6 • Erasmus Summer Program in Epidemiology and Biostatistics, Rotterdam, Netherland: 15 Aug-2 Sep 2011 • Gold certification of BMJ learning (Feb 2012) • Fellowship: Erasmus Summer Program in Epidemiology and Biostatistics, Rotterdam, Netherland: 13 Aug-

31 Aug 2012, Scholarship from NIHES (Netherlands Institute for Health Sciences) 4. Positions

• Director of Research at Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran (Feb 2014 – Present)

• Research Consultant at Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran (Sep 2013 – Present)

Page 3: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

3

• Researcher at Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, (Dec 2013 - Present)

• May 2009 – Sep 2011: Consultant of Research Projects, Consultant of Scholarship of Teaching, Member of Medical Education Department, Education Development Center of Iran University of Medical Sciences (www.iums.ac.ir)

• Feb 2007 – Sep 2011: Manager and Head of Methodology and Statistics Department of Gastrointestinal and Liver Diseases Research Center of Iran University of Medical Sciences

• Apr 2006 – Present: Board of Directors; and Head of the Applied Studies Department of Nikan Health Researchers Institute, Tehran, Iran (www.nhri.ir)

• Dec 2002 – Apr 2006: Head of the Research Department of Tehran Hepatitis Center, Tehran, Iran (www.hepmon.ir , www.thc.ir)

5. Clinical practice 1 Visiting patients suffering from liver diseases under supervision of Professor Seyed-Moayed Alavian in Tehran Hepatitis Center, Dec 2002- Dec 2008 2 Visiting patients as a general practitioner in my private clinic between April 2004 and June 2007

6. Publications (Research papers) in a. International journals (PubMed/ISI):

I. I. Hepatology and Gastroenterology65. Kabir A. Comments on: Predictive Value of Having Positive Family History of Cardiovascular Disorders, Diabetes Mellitus, Dyslipidemia, and Hypertension in Non-Alcoholic Fatty Liver Disease Patients. Acta Med Iran 2014:In Press 64. Sohrabi M, Zamani F, Ajdarkosh H, Rakhshani N, Ameli M, Mohamadnejad M, Kabir A, Hemmasi G, Khonsari M, Motamed N. Prevalence of Colorectal Polyps in a Group of Subjects at Average-risk of Colorectal Cancer Undergoing Colonoscopic Screening in Tehran, Iran between 2008 and 2013. Asian Pac J Cancer Prev 2014;15(22):9773-9 [IF: 1.27] 63. Kabir A. Comment on: Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners. J Res Med Sci 2014;In press 62. Keyvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, Saeedian F, Mooadi M, Motamed N, Ajdarkosh H, Khonsari M, Hemmasi G, Ameli M, Kabir A, Khodadost M. A Population Based Study on Hepatitis B Virus in Northern Iran, Amol. Hepat Mon 2014;14(8): e20540 [IF: 1.796] 61. Kabir A. Sampling bias, sample size, ordinal regression model, and competing risk in evaluating association between ABO blood group and severity of liver fibrosis in Hepatitis C virus patients. J Res Med Sci 2014;19(6):580 [IF: 0.68] 60. Kabir A, Moghimi M, Amini A. Intrafamilial Spread of Hepatitis B Virus: Some Comments. Int J Mol Epidemiol Genet 2014; 5(1):51-52 [IF: 1.3] 59. Kabir A. Control Group and Refusal Rate Critiques about Hepatitis C Virus Infection in HIV Positive Cases. Indian J Community Med 2014; 39(4):251 [IF: 1.661] 58. Kabir A. Comment on: New Onset Diabetes and Impaired Fasting Glucose after Liver Transplant: Risk Analysis and the Impact of Tacrolimus Dose. Exp Clin Transplant 2014: 12(1):85 [IF: 0.81] 57. Kabir A, Khalili D. Built-in bias in HCV clearance in acute HCV infection. J Hepatol. 2014;60(2):461. [IF: 9.9] 56. Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution of Metabolic Factors in Old Population of Kalaleh, Iran. Hepat Mon. 2013:13(10):e10640 [IF: 1.24] 55. Kabir A, Amini A, Moghimi M. Comments on: Knowledge of Medical Saudi Arabian Medical Students about Hepatitis B. Life Science Journal 2013;10(3):2167 [IF: 0.16] 54. Kabir A. Comment on: Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study. J Korean Med Sci. 2013 Jul;28(7):1114-5 [IF: 1.24] 53. Kabir A. Methodological and Statistical Comments on T Helper Cytokines Profile and Hepatitis C. Hepat Mon.2013. 13(6):e10641 [IF: 1.24] 52. Kabir A. Methodological and Statistical Comments on CASPIAN-III Study. Hepat Mon. 2013.13(5):e.10161 [IF: 1.24]

Page 4: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

4

51. Kabir A. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Ann Hepatol. 2013 May-Jun;12(3):506-7 [IF: 1.8] 50. Kabir A. Search in the Literature for Viral Hepatitis and Hepatocellular Carcinoma in Iran. Hepat Mon.2013.13(4):e.9172 [IF: 2.19] 49. Kabir A. Should We Rely on the Findings of Each Published Randomized Controlled Study? Hepat Mon.2013;13(3):e8355 [IF: 2.19] 48. Kabir A. Misconceptions About Nested Studies Matched Analysis, Significancy, Power, Normality and Multivariate Regression Analysis. Hepat Mon. 2013;13(2):e9052 [IF: 2.19] 47. Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol. 2013 Mar;12(2):213-9. [IF: 1.8] 46. Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of Hepatitis D in Eastern Mediterranean Region: Systematic Review and Meta Analysis. Hepat Mon. 2013;13(1):e8210 [IF: 2.19] 45. Ghasemi Sh, Kabir A, Ansari Jafari M, Jalali M, Amini A, Faghihi-Kashani AH, et al. Psychometric Properties of A Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis. Hepat Mon. 2012:12(12):e7650 [IF: 2.19] 44. Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Alaei-Andabili SH. Clinical features and seroepidemiology of anti-HDV antibody in patients with chronic hepatitis B virus infection in Iran: a meta-analysis. Hepat Mon 2011;11(12):960-67 [IF: 2.19] 43. Kabir A, Alavian SM. Comment on: Epidemiology of hepatitis B virus infection in Hamadan, western Iran. JRHS 2011;11(2):121-123 [IF: -] 42. Kabir A. Epidemiology of HCV Infection among Thalassemia Patients in Eastern Mediterranean Countries: Some Comments. IRCMJ 2011;13(2):144-145 [IF: 0.33] 41. Kabir A. Author’ reply: Knowledge, attitudes and practices of Iranian medical specialists. Hepat Mon.2011;11(1):41-43 [IF: 2.19] 40. Kabir A, Tabatabaei SV, Khaleghi S, Agah S, Faghihi Kashani AH, Moghimi M, Habibi Kerahroodi F, Alavian SH, Alavian SM. Knowledge, Attitudes and Practice of Iranian Medical Specialists regarding Hepatitis B and C. Hepat Mon 2010; 10(3): 176-182 [IF: 0.79] 39. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: A systematic review. Hemodial Int 2010;14(3):253-62 [IF: 1.54] 38. Boghratian AH, Hashemi H, Kabir A. Gender-related differences in upper gastrointestinal endoscopic findings: a review of 4,700 cases. J Gastrointest Cancer 2009; 40:83–90. [IF: -] 37. Alavian SM, Ahmadzad-Asl M, Bagheri Lankarani K, Shahbabaie MA, Bahrami Ahmadi A, Kabir A.Hepatitis C Infection in the General Population of Iran: A Systematic Review. Hepat Mon 2009; 9(3): 211-223 [IF: 0.73] 36. Moghimi M, Marashi SA, Kabir A, Taghipour HR, Faghihi-Kashani AH, Ghoddoosi I, Alavian SM. Knowledge, Attitude, and Practice of Iranian Surgeons about Blood-Borne Diseases. J Surg Res 2009 Jan;151(1):80-4. Epub 2008 Feb 1 [IF: 2.02] 35. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon 2008; 8(4):281-294 [IF: 0.73] 34. Kabir A, Keshvari M, Kashani AH, Alavian SM. Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs. Hum Vaccin 2008 Sep-Oct;4(5):379-83. Epub 2008 Sep 2 [IF: 3.14] 33. Kabir A, Alavian SM, Keyvani H. Distribution of HCV genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 2006 Oct 2;5:4 [IF: 1.88] 32. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res 2006 Dec;36(4):265-71. Epub 2006 Sep 11 [IF: 2.2] 31. Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour". Sex Transm Infect 2005 Apr;81(2):185 [IF: 3.39] 30. Alavian SM, Kabir A, Torabi HR. The efficacy of lamivudine in hepatitis B-related cirrhosis. Hepat Mon 2004;4(8):165-9 [IF: -] 29. Alavian SM, Kabir A, Hajarizadeh B, Nayebpour M, Haji-Beigi B, Dorodi T, Baralle FE. Combination therapy of Interferon-alpha 2b (PDferon B®) and ribavirin for Chronic Hepatitis C. Hepat Mon 2004;4(6):13-16 [IF: -]

Page 5: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

5

II. Cardiovascular diseases28. Kelarijani RB, Mandegar MH, Chalian H, Kabir A, Chalian M, PoorAttar F, Saeedi SJ. Cardiac resynchronization therapy in severe heart failure: does etiology affect? Ind Heart J 2014 (In press) 27. Rasouli Ghahroudi AA, Rokn AR, Khorsand A, Aghajani H, Amini A, Shamshiri AR, Rahimi H, Kabir A.Designing and standardizing a questionnaire for evaluating knowledge, attitude, and practice of Iranian adults with cardiovascular diseases about oral health. Arya Atheroscler 2013;9(6):350-6 [IF: -] 26. Kabir A, Sarrafzadegan N, Amini A, Safi Aryan R, Habibi Kerahroodi F, Rabiei K, Taghipour HR, Moghimi M. Impact of cardiac rehabilitation on metabolic syndrome in Iranian patients with coronary heart disease: the role of obesity. Rehabil Nurs. 2012 Mar-Apr;37(2):66-73 [IF: 0.55] 25. Taghipour HR, Naseri MH, Safiarian R, Dadjoo Y, Pishgoo B, Mohebbi HA, Daftari Besheli L, Malekzadeh M, Kabir A. Quality of life one year after coronary artery bypass graft surgery. IRCMJ 2011; 13(3):171-177 [IF: 0.33] 24. Kabir A, Sarrafzadegan N. The real role of exercise versus medication in lipid profile of patients referred to a cardiac rehabilitation program. Eur J Cardiovasc Prev Rehabil 2011;18(4):680-681 [IF: 2.63] 23. Sarrafzadegan N, Rabiei K, Kabir A, Sadeghi M, Khosravi A, Asgari S, Taghipour HR, Roohafza HR. Gender differences in risk factors and outcomes after cardiac rehabilitation. Acta Cardiologica 2008;63(6):763-770 [IF: 0.61] 22. Kelarijani RB, Saleh DK, Chalian M, Kabir A, Ahmadzad Asl M, Dadjoo Y. Gender- and age-related outcomes of cardiac resynchronization therapy: A pilot observational study. Gend Med 2008 Dec;5(4):415-422 [IF: 2.1] 21. Sarrafzadegan N, Rabiei K, Kabir A, Asgari S, Tavassoli A, Khosravi A, Chalian H. Changes in lipid profile of patients referred to a cardiac rehabilitation program. Eur J Cardiovasc Prev Rehabil 2008 Aug;15(4):467-72 [IF: 2.63] 20. Sarrafzadegan N, Rabiei K, Shirani Sh, Kabir A, Mohammadifard N, Roohafza HR. Drop-out predictors in cardiac rehabilitation programmes and the impact of sex differences among coronary heart disease patients in an Iranian sample: a cohort study. Clin Rehabil 2007 Apr;21(4):362-72 [IF: 2.12]

III. Others19. Kabir A, Moghimi M. Re: Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ Open 2014; http://www.bmj.com/content/349/bmj.g6015/rr/780110 published at 15 Nov 2014 [IF: 2.063] 18. Cyrus A, Kabir A, Goodarzi D, Talaei A, Moradi A, Rafiee M, Moghimi M, Shahbazi E, Farmani E. Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic Hyperplasia. Korean J Urol 2014;55(12):814-820 [IF: 0.202] 17. Borghei-Razavi H, Haghighatkhah H, Moharramzad Y, Yahyavi ST, Khalatbari MR, Borghei-Razavi M, Kabir A. Instrumentation of low grade Lumbar Degenerative Spondylolisthesis, is total laminectomy Inevitable? (Case Series). J Spine Neurosurg 2014;S2 [IF: -] 16. Cyrus A, Kabir A, Goodarzi D, Moghimi M. The effect of adjuvant vitamin C after varicocele surgery on sperm quality and quantity in infertile men: a double blind placebo controlled clinical trial. International Braz J Urol 2014 (In Press) [IF: 0.74] 15. Zendehdel R, Tayefeh-Rahimian R, Kabir A. Chronic exposure for Chlorophenol related compounds in production workplace and lung cancer: A meta-analysis. APJCP 2014;15(13):5149-53 [IF: 1.27] 14. Chaichian S, Kabir A, Moghimi M, Mehdizadehkashi A. Re: “Hardly worth the effort”? Medical journals’ policies and their editors’ and publishers’ views on trial registration and publication bias: quantitative and qualitative study. BMJ Open 2014; http://www.bmj.com/content/347/bmj.f5248/rr/686587 published at 13 Feb 2014 [IF: 2.063] 13. Kabir A, Moghimi M, Amini A. Doubt about Prediction Role of S100B Protein for Brain Death. Arch Trauma Res 2014;3(2):e17351[IF: -] 12. Mehdizadehkashi A, Kabir A, Chaichian S, Moghimi M. Criticizing the effect of ovarian suspension on adhesions in laparoscopic surgery for endometriosis. Hum Reprod 2014;29(7):1596-7 [IF: 4.67] 11. Cyrus A, Moghimi M, Jokar A, Rafeie M, Moradi A, Ghasemi P, Shahamat H, Kabir A. Model determination of delayed causes of analgesics prescription in the emergency ward in Arak, Iran. Korean J Pain 2014; 27(2):152-61 [IF: 0.16] 10. Arhami Dolatabadi A, Amini A, Hatamabadi H, Mohammadi P, Derakhshanfar H, Tabatabaee SM, Moghimi M, Kabir A. A comparison of the accuracy and reproducibility of focused abdominal sonography for trauma performed by emergency medicine and radiology residents. Ultrasound Med Biol 2014;40(7):1476-1482 [IF: 2.45] 9. Roohafza HR, Kabir A, Sadeghi M, Shokouh P, Aalaei-Andabili SH, Mehrabi Y, Sarrafzadegan N. Effect of

Page 6: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

6

psychological distress on weight concern and weight control behaviors. Arch Iran Med 2014;17(9):608-12 [IF: 1.108] 8. Mossayebi E, Arab Z, Rahmaniyan M, Almassinokiani F, Kabir A. Prediction of Neonates' Macrosomia with Maternal Lipid Profile of Healthy Mothers. Pediatr Neonatol. 2014;55(1):28-34 [IF: 0.93] 7. Bidari A, Hassanzadeh M, Ghavidel Parsa B, Kianmehr N, Kabir A, Pirhadi S, Sayfi M, Toutounchi M, Fattahi F, Zandi Karimi F. Validation of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int. 2013;33(12):2999-3007 [IF: 2.21] 6. Amini A, Dindoost P, Moghimi M, Kariman H, Shahrami A, Arhami Dolatabadi A, Ali-Mohammadi H, Alavai-Moghaddam M, Derakhshanfar H, HatamAbadi HR, Heidari K, Alamdari Sh, Kalantar Meibodi M, Shojaee M, Foroozanfar MM, Hashemi B, Sabzeghaba A, Kabir A. Clinical audit of emergency unit before and after establishment of the emergency medicine department. J Pak Med Assoc 2012;62(2) :154-8 [IF: -] 5. Bahador H, Pazouki A, Kabir A. Effectiveness of Continuing Medical Education considering participant’s idea in Iran University. J Pak Med Assoc 2010;60(6):435-439 [IF: -] 4. Subhan MM, Kabir A. Evaluation of the Effect of Islamic Fasting on Lung Volumes and Capacities in Healthy Persons. Saudi Med J 2008 Apr;29(4):626-7 [IF: 0.3] 3. Mohebbi HA, Mehrvarz S, Kashani MT, Kabir A, Moharamzad Y. Predicting negative appendectomy by using demographic, clinical, and laboratory parameters. Int J Surg 2008 Apr;6(2):115-8. Epub 2008 Jan 13 [IF: 1.44] 2. Javad Moosavi SA, Kabir A, Moghimi A, Chehrei A, Bagheri rad M. Evaluation of the Effect of Islamic Fasting on Lung Volumes and Capacities in the Healthy Persons. Saudi Med J 2007 Nov; 28(11):1666-70 [IF: 0.3] 1. Mohebbi HA, Panahi F, Kabir A. Comparing Conscripts to non-Conscripts who have already been selected for appendectomy. Military Med 2006 Nov;171(11):1110-1112 [IF: 0.92]

b. National journals:

43. Akhundzadeh E, Yavari P, Mehrabi Y, Kabir A. Survival rate of one, three and five years of patients with gastric cancer using meta-analysis. Iran J Epid 2014;In Press 42. Zendehdel R, Tayefeh-Rahimian R, Kabir A. Chronic exposure to chlorophenol related compounds in production workplace and kidney cancer: A meta-analysis. J Health Field 2013;1(3):1-6 41. Barkhordari M, Keshavarz Mohammadi N, Ramezankhani A, Kabir A, Mansouri T, Fakhrzadeh H. Designing and validating a tool for educational needs assessment of patients with coronary artery heart diseases. Iranian Journal of Cardiovascular Nursing 2014;(In press) 40. Amini A, Eghtesadi R, Feizi AM, Mansouri B, Kariman H, Arhami Dolatabadi A, Hatamabadi H, Kabir A.Sonographic Optic Nerve Sheath Diameter as a Screening Tool for Detection of Elevated Intracranial Pressure. Emergency (2013); 1(1): 15-19 39. Hosseini Shekarabi K, Kabir A. Assessment of the Diagnostic and Therapeutic Characteristics of Patients with Urologic Trauma Referred to Hazrat Rasoul-e-Akram Hospital between 2007 and 2008. Razi Journal of Medical Sciences 2011;17(80):1-7 38. Haghdoost AA, Shoghi Shafagh Aria F, Momtazmanesh N, Changiz T, Mohammdi A, khazaeli P, Dehghani MR, Hamzeh B, Alizadeh M, Mohammadi N, Mansoorian MR, Noorian AA, Ahmadi S, Kabir A, Vahidshahi K. Ranking of Universities of Medical Sciences based on their educational activities: Setting Indicators. Teb and Tazkiyeh 2010;76(1):65-72 37. Moghimi M, Marashi SA, Kamani F, Kabir A, Fazel I, Ghasemzadeh H, Karimi MA. LONG TERM EFFECTS OF KIDNEY DONATION ON BLOOD PRESSURE AND KIDNEY FUNCTION OF DONORS. Med J Hormozgan Uni 2008;12(2):75-82 36. Moghimi M, Marashi A, Kamani F, Kabir A, Mofid J. Evaluation of gastric surgery complications and their management in patients hospitalized at Ayatollah Taleghani hospital. JQUMS 2009; 13(2):11-16 35. Moghimi M, Marashi SA, Kamani F, Kabir A. Evaluation of axillary lymph node involvement in patients with breast cancer according to sentinel lymph node involvement. Birj Univ Med Sci J 2009;15(4):104-111 34. Bahar MA, Manafi A, Bouduhi N, Karimi H, Hormazdi M, Esfandi S, Abdollahi Sabet S, Kabir A.Assessment of burn wound infection by swab and biopsy culture: a comparative study. MJIRI 2008 Aug;22(2):80-85 33. Malekzadeh R, Alavian SM, Kabir A, Ahanchi N. Passive and Active Immunization in Prevention of Vertical Transmission of HBV Infection in Infants of HBsAg Positive Mothers. GOVARESH Fall 2004; 9(3):181-187. 32. Kabir A, Torkan F, Hakemi L. Evaluation of menarche age and relevant factors in Iranian female participants of the 1381 student Olympic games. IJEM 2007;8(4):383-391 31. Bakhshian Kelarijani R, Kazemi Saleh D, Dadjoo Y, Naseri MH, Naserbakht M, Kabir A, Pourmansouri L.

Page 7: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

7

PREMATURE CORONARY ARTERY DISEASE IN MILITARY AND NON-MILITARY INDIVIDUALS. ARYA Atherosclerosis Journal 2007, 3(3): 157-161 30. Faghihi Kashani AH, Kabir A, Javad Moosavi SA. Pulmonary function in ulcerative colitis cases in comparison with controls. MJIRI 2008 Feb; 21(4): 196-202 29. Alavian SM, Kabir A, Hajarizadeh B, Nayebpour M, Dorodi T, Baralle FE. Preliminary Report of Interferon α2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study. Shiraz E-Medical Journal 2006 Jun;7(1):1-8 28. Alavian SM, Foroutan Pishbijary H, Mirmomen Sh, Ghofrani H, Kabir A. EFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C MJIRI WINTER 2006; 19(4):291-295 27. Kabir A, Torkan F, Hakemi L. Prevalence of Anemia in Iranian athletes participating in the camp for selecting female national teams. Tebe Varzeshi 2003;29:46 26. Kabir A, Torkan F, Hakemi L. General health assessment of in Iranian athletes participating in the camp for selecting women national teams. Hakim 2008, 10(4):34-39 25. Kabir A, Keshvari M, Alavian SM. Efficacy of HBV vaccination in people with isolated anti-HBc antibody. Govaresh 2007;12(2):86-91 24. Kabir A, Torkan F, Hakemi L. Evaluation of Age at Menarche and Relevant Factors in Physically Active Iranian Girls. International Journal of Endocrinology and Metabolism 2007; 2: 52-60 23. Mirhashemi S, Mirhashemi SAH, Ghanjal A, Mohebbi HA, Delavari AR, Saghafinia M, Kabir A, Assessment of Triage and Transportation in Bam Earthquake Casualties whom were Hospitalized in Baqiyatallah and Some Other Tehran Hospitals. J of Military Medicine 2005;7(3):225-30 22. Mohebbi HA, Abolghasemi H, Towliat Kashani SM, Fanaii SA, Kabir A. The efficiency of horse collagen (Antema) in hemostasis of bleeding due to dental procedures, pilonidal sinus surgery, hemorrhoidectomy and laminectomy. SJIBTO 2006;3(3):243-251 21. Faghihi Kashani AH, Bahar MA, Kabir A. Fibrinogen role in probable association between helicobacter pylori infection and ischemic heart diseases. J of Iran Uni of Med Sci 2005;12(47):107-114 20. Vahid T, Kafaee J, Kabir A, Yektaparast B, Alavian SM. Hepatitis B prevalence & risk factors in blood donors in Ghazvin, Iran. Hakim 2005;8(1):8-15 19. Ansarin H, Kabir A, Mehregan R, Hosseini J. Comparison of spironolactone plus cyproterone acetate plus cyproterone compound with spironolactone and cyproterone compound in hirsutism: A randomized clinical trial. Ir J Dermatol 2004;7(3):156-65 [My name was omitted in this number that is added in Year 2006, Vol. 8, No. 6, Page 521 as a modification in “letter to Editorial” part] 18. Alavian SM, Kabir A, Haji Beigi B, Doroudi T, Saber HR. The effect of combination therapy with PD Feron-B and Ribavirin in patients with Hepatitis C: A quasi-experimental study. Physiol & Pharmacol J 2004;8(1):71-81 17. Mohebbi HA, Panahi F, Moussavi Naieni SM, Kabir A. Comparison of Diagnostic Accuracy of Acute Appendicitis in active duty soldiers with Control Group. J Military Med 2004;6(1):7-12 16. Faghihi Kashani AH, Bitarafan S, Zangeneh Kazemi A, Kabir A. The relationship between gallstone formation and diabetes mellitus. J of Iran Uni of Med Sci 2004;11(42):597-604 15. Mohebbi HA, Mehrvarz Sh, Toliat SM, Kabir A. Negative appendectomy and its related factors in 1211 cases undergoing appendectomy. J of Iran Uni of Med Sci 2004;11(41, Extra 1):473-82 14. Shooshtarizadeh T, Mehrazma M, Haji Aliloo Sami S, Kabir A. A prospective study of the diagnostic value of core needle biopsy and fine needle aspiration in bone and soft tissue lesions. J of Iran Uni of Med Sci 2004;11(41, Extra 1):433-40 13. Hashemi SM, AzaliHagh M, Bagheri M, Kabir A. Histopathologic and anatomic correlation of primary gastric cancers. J of Iran Uni of Med Sci 2004;11(40):319-26 12. Bahar MA, KashaniFaghihi AH, Haghighat P, Kabir A, PoorEslami M. Association between Helicobacter Pylori infection and coronary heart disease. J of Iran Uni of Med Sci 2004;11(39):13-22 11. HaghAzali M, ShahradBejestani H, Kabir A, ShooshtariZadeh T. Comparison of vitamin B12 level and its neurological signs and symptoms in well-controlled diabetic patients with poor-controlled ones. J of Iran Uni of Med Sci 2004;10(38, Extra 2):859-68 10. Alavian SM, Kabir A, Hashemi A. Evaluation of interferone-alpha type 2a (ROFERON) on patients with chronic hepatitis C. J of Iran Uni of Med Sci 2003;10(33):61-74 9. Sardarizadeh H, Kabir A, Nodeh AA, Hoshang H. Comparison of reception with discharge diagnosis in children referred to ALI-ASGHAR and RAHNEMOON Hospitals in 1995. J of Iran Uni of Med Sci 2003;10(33):45-54 8. Zargar MA, Shadpour P, Kabir A, FiroozabadiDehghanei MH. Evaluation of the relationship between serum free Testosterone and Gleason score of the prostatic biopsy in patients with prostate cancer. Ir J Urol 2003;9(36):1-7

Page 8: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

8

7. Ansarin H, Kabir A, Mirishekarab AA. Comparison of dermatologic patients’ quality of life with healthy people.J of Iran Uni of Med Sci 2003;9(32, Extra):649-58 6. Faghihi AH, Kabir A, Basi A. Comparison of frequency of helicobacter pylori infection in subgroup of patients with non-ulcer dyspepsia. J of Iran Uni of Med Sci 2003;9(31):557-66 5. Poormoghim H, Kabir A, Zahedi L. A case report of limited systemic sclerosis with symptomatic pericardial effusion. J of Iran Uni of Med Sci 2002;9(29):181-7 4. Sardarizadeh H, Kabir A. A case report of bronchogenic cyst in a child with review of diagnosis and treatment. Jof Iran Uni of Med Sci 2002;9(28):57-62 3. Mashayekhi M, Kabir A, Ahanchi N, Sadedel B. Review artcle of Diabetic foot syndrome and its prevention. Hooma Scientific Journal 2001;3(10):11-20 2. Kabir A, Hashemi M, Danayi N, Rashidpoor A. Assessment of the attitude of the attendance in 1st National Medical Students' Congress, Semnan University of Medical Sciences. Avaye Elm 2001;??? 1. Sardarizadeh H, Haghdoost AA, Kabir A. Desquamative interstitial Pneumonia in a Twelve day-old Neonate in coincidence with staphylococcus epidermidis septicemia: a case report. J of Iran Uni of Med Sci 2001;8(23):25-29 c. Publications (Persian Books):

1. Ali Kabir, eds. Principals of Research Methodology in Medical Sciences. Noor e Danesh Publication Institute, Tehran - Iran (2002) [ISBN: 964-7757-27-1], Second publication: 2005, Third publication: 2007 2. Ali Kabir, eds. Methods of Designing Questionnaire in Medical Sciences, Fekrat Publication, Tehran - Iran (2002) [ISBN: 964-91739-4-3], Second publication: 2006 3. Ali Kabir, eds. Designing and Analysis of Observational-Analytic Studies, Sara Publication, Tehran – Iran (2002) [ISBN: 964-93897-6-8], Second publication: 2007 4. One of the consultant of “Understanding the dialysis”, Published by “Noor e Danesh Publication Institute, Tehran, Iran, 2009 (1st ed.) [ISSBN: 978-964-413-128-8]

d. Under review/writing Manuscripts:

1. Naseri MH, TaghiPour HR, Kabir A, Davoudi A, Naserbakht M, Jalali AR, Naddafnia H. On-pump versus off-pump coronary artery bypass graft surgery: outcomes and complications in an Iranian study. 2. Kabir A, Alavian, SM, Shahkarami S. Hepatitis B and C risk factors in a referral center in Tehran, Iran. (In press) 3. Kabir A, Behnava B, Keshvari M, Alavian SM. Intrafamilial transmission of hepatitis B virus in carriers of HBV in Blood donors. (under review) 4. Kazemi Saleh D, Kalantar MH, Kabir A, Moradi M, Moshkani Farahani M, Bakhshian Kelarijani R. Intra Hospital and Long Term Outcomes of Coronary Artery Intervention in Diabetic Patients. 5. Kazemi Saleh D, Kalantar MH, Kabir A, Moradi M, Moshkani Farahani M, Bakhshian Kelarijani R The predictors of successfulness in percutaneous coronary arteries intervention in Iran Prevention and Control. 6. Kelarijani RB, Mandegar MH, Chalian M, Kabir A, Chalian H, Moshkani Farahani M, PoorAttar F. Cardiac resynchronization therapy in severe heart failure: is QRS duration an appropriate factor for selecting patients? 7. Faghihi Kashani AH, Kabir A, Alborzi A. Comparison of therapeutic effect of omeprazole with metoclopramide in patients with non-ulcer dyspepsia. (In press) 8. Alavian SM, Kabir A, Laskari A, Bagheri Lankarani K, Shahbabaie MA, Ahmadzad-Asl M. Epidemiology of hepatitis C virus infection among injecting drug users in Iran: a meta analysis 9. Es-haghi MA, Kabir A, Golmohammadi A, Noori S, Kabir K, Moghimi M. Rate of coverage and adverse effects of active immunization of viral infections in 6283715 persons in Tehran in 2008-2009 10. Es-haghi MA, Kabir A, Golmohammadi A, Noori S, Kabir K, Moghimi M. Rate of coverage and adverse effects of active immunization of bacterial infections in 6283715 persons in Tehran in 2008-2009 11. Salimi Gh, Yoosefi AR, Faghihi-Kashani AH, Faghihi-Kashani I, Kabir A. Satisfaction of Patients Hospitalized in Training Hospitals of Isfahan from Presonnel Relationships and Health Services. (In press) 12. Haghdoost AA, Shoghi F, Momtazmanesh N, Changiz T, Mohammadi A, Khazaeli P, Dehghani MR, Hamze B, Alizadeh M, Mohammadi N, Mansourian MR, Noorian AA, Ahmady S, Kabir A, Vahidshahi K. Ranking of Universities of Medical Sciences based on their educational activities: Setting Indicators 13. Kabir A, Alavian SM, Rezaie M, Bagheri Lankarani K, Shahbabaie MA, Ahmadzad-Asl M. Prevalence of Hepatitis C Infection in Iranian Hemophiliacs: A systematic review and meta-analysis

Page 9: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

9

14. Cyrus A, Kabir A, Moradi A. Finasteride BPH MetS 15. Davoodi M, Belash Abadi S, Aalaei-Andabili SH, Kabir A. Comparison of Image Quality of Low Voltage 64-slice multidetector CT Angiography (80 Kilovoltage) with Standard Condition (100 Kilovoltage) in Patients Suspicious to Pulmonary Emboli 16. Rasouli Ghahroudi AA, Khorsand A, Rokn AR, Aghajani H, Jalali M, Masudi S, Rahimi H, Kabir A. Oral Health Status, Knowledge, Attitude and Practice of Patients with Heart Disease in Iran 17. Taha I, Alavian SM, Kabir A. SR and MA of HAV in Middle East 18. Roohafza HR, Kabir A, Sadeghi M, shokouh P, Ahmadzad-Asl M, Khadem Maboudi AA, Sarrafzadegan N. Stress as a risk factor for non compliance with treatment regimens of diabetes and hypertensive patients 19. Mirafzal ?, Kabir A. The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose 20. Mirafzal ?, Kabir A. Risk factors correlated with in-hospital adverse outcomes in methadone overdose 21. Mirafzal ?, Kabir A. Methadone in children 22. Kabir A, Nazarzadeh M, Ayubi E, Noorafkan Z, Sabour S, Haghdoost AA, Semnani ?. The effect of HBV vaccine in loss of HBV DNA in patient with chronic hepatitis B, a meta-analysis 23. Zendehdel R, Tayefeh-Rahimian R, Kabir A. Meta-Analysis of Chlorophenol related Compound Exposure in Pesticide Production as a Risk Factor for Prostate Cancer 24. Zamani F. Kabir A. Cohort profile of Amol study. 25. Zamani F. Kabir A. Cutoff point for waist circumference in metabolic syndrome in Iran. 26. Pazouki A, Abed, Kabir A, Jesmi F, Jananai L, Mriazi S, Alibeigi, Mir. Efficacy of Traditional Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Mini Gastric Bypass on Resolution of Diabetes (type II) in Morbid Obese Patients. 27. Kabir A, et al. TG/HDLc as a predictor of incidence of CAD and pre-diabetes status: a systematic review and meta-analysis. 28. Kabir A, et al. The effect of HBV vaccine on loss of HBV DNA in chronic hepatitis B patients: A meta-analysis.

e. Abstracts1. Kabir A, Sarrafzadegan N, Amini A, Safi Aryan R, Habibi Kerahroodi F, Rabiei K, Taghipour HR, Moghimi M. Impact of cardiac rehabilitation on metabolic syndrome in Iranian patients with coronary heart disease. Am JEpidemiol 2011;173(Suppl 11):S171-S171 [IF: 5.2] 2. Alavian SM, Ahmadzad-Asl M, Bagheri Lankarani K, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. ASystematic Review of Hepatitis C Infection in General Population of Iran. Am J Epidemiol 2011:173(Suppl 11):S23-S23 [IF: 5.2] 3. Alavian SM, Kabir A, Bahrami Ahmadi A, Bagheri Lankarani K, Shahbabaie MA, Ahmadzad-Asl M. A systematic review of Hepatitis C infection in hemodialysis patients in Iran. Am J Epidemiol 2011;173(Suppl 11):S266-S266 [IF: 5.2] 4. Kelarijani RB, Mandegar MH, Chalian H, Kabir A, Chalian M, PoorAttar F, Saeedi SJ. Cardiac resynchronization therapy in severe heart failure: does etiology affect? Eur J Med Res 2008;13(Suppl 1):13 [IF: 1.1] 5. Kabir A, Alavian SM, Amini N, Aalaei-Andabili SH, Hosseini SYS. Meta-Analysis of Iranian publications about seroepidemiology of hepatitis D virus infection. Hepatol Int 2013 7: (S461) [IF: 2.64]

7. Poster Presentation 10. Kabir A, Moghimi M, Marashi SA, Taghipour HR, Faghihi-Kashani AH, Ghoddoosi I, Alavian SM. knowledge, attitude and practice of Iranian surgeons about blood-borne diseases. Poster presentation in 8th national congress of gastroenterology and hepatology in Isfahan University, Iran, November 25-28 2008 9. Hajarizadeh B, Kabir A, Alavian SM, Ahmadzad M, Haghdoost AA, Shamshiri AR, Moeenzadeh AM, Pirnazar O, Talebizadeh N, Bagheri-Lankarani K. Estimation of hepatitis B prevalence among general population in Iran: a systematic review. Poster presentation in 8th national congress of gastroenterology and hepatology in Isfahan University, Iran, November 25-28 2008 8. Hashemi SM, AzaliHagh M, Bagheri M, Kabir A, Histopathologic and anatomic correlation of primary gastric cancers, Poster presentation at 3rd International Congress on Gastroenterology and Hepatology in Iran, Tehran University of Medical Sciences, October 18-22 2003

Page 10: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

10

7. Kabir A, Bahar MA, KashaniFaghihi AH, Haghighat P, Association between Helicobacter Pylori infection and coronary heart disease, Poster presentation at 3rd International Congress on Gastroenterology and Hepatology in Iran, Tehran University of Medical Sciences, October 18-22 2003 6. Kabir A, Alavian SM, Vahid T, Kafaee J, Hepatitis B prevalence & risk factors in blood donors in Ghazvin, Iran, Poster presentation at 3rd International Congress on Gastroenterology and Hepatology in Iran, October 18-22 2003 5. Torkan F, Kabir A, Hakemi L, General health assessment of in Iranian athletes participating in the camp for selecting women national teams, Poster presentation at European Congress of Sports Medicine, Hasselt, Belgium, May 14-16 2003, P62:109 4. Torkan F, Kabir A, Hakemi L, Prevalence of Anemia in Iranian athletes participating in the camp for selecting female national teams, Poster presentation at European Congress of Sports Medicine, Hasselt, Belgium, May 14-16 2003, P31:92 3. Kabir A, Alavian SM, Haji Beigi B, Dorodi T, Saber HR, Combination therapy with PDferon-B plus ribavirin in patients with hepatitis C, Poster presentation at 16th Iranian Congress of Physiology and Pharmacology, Tarbiat Moderres University, Tehran, Iran, May 9-13 2003 2. Faghihi Kashani AH, Bitarafan S, Zangeneh Kazemi A, Kabir A, The relationship between gallstone formation and diabetes mellitus, Poster presentation at 3rd National Medical Students' Congress, Tehran University of Medical Sciences, Iran, December 24-26 2002 1. Chehrei A, Kabir A, Poormoghim H, Fazlipoor A, Comparison of therapeutic effect of salvia oil with piroxicam jell in osteoarthritits of knee, Poster presentation at National Medical Students' Congress, Tabriz University of Medical Sciences, Iran, May 22-25 2002 8. Oral Presentation 8. Behnava B, Kabir A, Keshvari M, Soleimanian H, Attarchi Z, Karimi AA, Haji-Beigi B, Alavian SM, Intrafamilial transmission of hepatitis B virus in carriers of HBV in Blood donors, 2nd National Virology Congress of Iran, "Iran Society of Virology" and "Razi Vaccine Research & Serum Production Institute", Imam Khomeini Hospital, Tehran, Iran, February 13-15 2004 7. Keshvari M, Alavian SM, Kabir A, Soleimanian H, Attarchi Z, Karimi AA, Haji-Beigi B, Behnava B, Efficacy of HBV vaccination in people with isolated anti-HBc antibody, 2nd National Virology Congress of Iran, Iran Society of Virology and Razi Vaccine & Serum Research Institute, Imam Khomeini Hospital, Tehran, Iran, February 13-15 2004 6. Kabir A, Alavian SM, Hajarizadeh B, Nayebpour M, Haji Beigi B, Dorodi T, Baralle FE, Preliminary report of Interferon α2b in combination with ribavirin for 48 weeks for treatment of Iranian patients with chronic hepatitis C: a quasi-experimental study, 19th International Medical Sciences Students’ and Young Physicians’ Congress, Istanbul Faculty of Medicine, Istanbul University, Turkey, May 5-9 2004 5. Kabir A, Ansarin H, Mirishekarab AA, Comparison of dermatologic patients' quality of life with healthy people, 18th International Medical Sciences Students’ and Young Physicians’ Congress, Istanbul Faculty of Medicine, Istanbul University, Turkey, May 8-11 2003 4. Kabir A, Faghihi AH, Basi A, Comparison of frequency of helicobacter pylori infection subgroup of patients with non-ulcer dyspepsia, 18th International Medical Sciences Students’ and Young Physicians’ Congress, Istanbul Faculty of Medicine, Istanbul University, Turkey, May 8-11 2003 3. Kabir A, Sardarizadeh H, Nodeh AA, Hoshang H, Comparison of reception with discharge diagnosis in children referred to ALI-ASGHAR and RAHNEMOON Hospitals in 1995, 3rd National Medical Students' Congress, Tehran University of Medical Sciences, Iran, December 24-26 2002 2. Alavian SM, Kabir A, Hashemi A, Evaluation of interferone-alpha type 2a (ROFERON) on patients with chronic hepatitis C, Seminar of the Hepatitis, prevention and treatment, Baqiyatallah University of Medical Sciences, Imam Khomeini Hospital, Tehran, Iran, October 23-25 2001 1. Kabir A, Zargar MA, Shadpour P, FiroozabadiDehghanei MH, Evaluation of the relationship between serum free Testosterone and Gleason score of the prostatic biopsy in patients with prostate cancer, 2nd National Medical Students' Congress, Gholestan University of Medical Sciences, Iran, October 10-11 2001

9. Teaching Experiences 2. Different courses about Public Health, Epidemiology, Methodology and Research for PhD students, Master or Bachelor students in Shahid Beheshti University of Medical Sciences, Tehran, Iran; Iran University of Medical Sciences, Tehran, Iran from 2009 till now

Page 11: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

11

1. Teacher and Mentor of workshops on Search Strategy, Writing a scientific paper, SPSS, General Research Methodology, Preparing a Standard Questionnaire, Observational-Analytical Studies, Sampling and Calculating Sample Size, Systematic Review and meta-analysis, and data mining from July 23 1999 till Present

10. Research Interest 1. Research Methodology, Meta analysis, Statistical Modeling, Simulation 2. Gastroenterology, particularly Hepatology; cardiovascular disease 3. Information Mastery, Scientometrics

11. Membership • Member of Middle East Liver Disease Center as a researcher: 2012-Present

(http://meldcenter.com/main/index.php/en/researcher/dr-ali-kabir)• Member of Iranian Registry of Clinical Trials, Tehran, Iran: 2012 (March)-Present (www.irct.ir)• Member of Iranian Epidemiologic Associations: 2010-Present • Affiliated member of regional knowledge Hub for HIV/AIDS surveillance, Kerman, Iran: 2010-present • Member of National Elites Foundation of Iran: December 2009 – Present • Member of Iranian Medical Council, Iran, I.R.: 2002-Present [M.C. No.: 92567] • Member of Tehran Hepatitis Center: 2001-Present • Member of Board of Directors of Nikan Health Researchers Institute, 2005(Nov) – Present • Member of Sport Medicine Federation of Islamic Republic of Iran, Education and Research Committee:

2004(July)-2007(June) • Member of Trauma Research Center, Baqyiatallah University of Medical Sciences and Health Services:

2002-2004 • Member of Medical Students Research Committee of Iran University of Medical Sciences and Health

Services: 1997-2002 12. Other Skills

• Expert in software: SPSS, EPI, STATA, R, ArcGIS, Arcview, Treeage, and Microsoft Office (Word, Excel, Power point)

13. Additional Courses and Trainings 1. 2013, Data Mining, Shahid Beheshti University of Medical Sciences 2. 17-20 September 2011, First Iranian Summer Program of Epidemiology and Biostatistics: Disease modeling workshop and Arc GIS software workshop, holding by Pasteur Institute of Iran, Iranian Epidemiological Association and Research Center for Disease Modeling 3. September 21-22 2005, Having passed the Teaching Methods Workshop held by Education Development Center (EDC) of Iran University of Medical Sciences in Sport Medicine Federation of Islamic Republic of Iran, Tehran, Iran, Time: 12 hours 4. September 13-14, 2005: 7th Seminar of Sport Medicine in Females held by Tehran University of Medical Sciences, Imam Khomeini Hospital, Imam Hall, Tehran, Iran, Time: 12 hours 5. May 7-9 2004: The First Congress of STEM CELL AND GENE THERAPY in CLINICAL PRACTICE held by Istanbul University of Medical Sciences, Turkey, Time: 16 hours 6. September 16-17 2003, The First International Team Physician Development Course in Iran held by International Federation of Sports Medicine in Enghelab Sport Club, Tehran, Iran, Time: 16 hours 7. January 22-24 2003, The First International Course of Sport Medicine in Iran held by The International Olympic Committee Medical Commission and Olympic Solidarity in Enghelab Sport Club, Tehran, Iran, Time: 16 hours 8. January 2 2000, Having passed the Survival Analysis Workshop for Medical Students held by Medical Students Research Committee of Iran University of Medical Sciences, Tehran, Iran, Time: Three hours 9. October 19 1999, Having passed the Specialty Sampling and Calculating Sample Size Workshop for Medical Students held by Medical Students Research Committee of Iran University of Medical Sciences, Tehran,

Page 12: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

12

Iran, Time: Three hours and 30 minutes

14. Awards 12. Best research student at Shahid Beheshti University of Medical Sciences, Tehran, Iran, 15th annually Abooreihan Research Festival, Dec 2014 11. Best PhD student of Epidemiology in Shahid Beheshti University of Medical Sciences, Tehran, Iran, 9th annually Educational Festival, April 2014 10. 3rd Researcher among PhD students of the Shahid Beheshti University of Medical Sciences, Tehran, Iran, 7th annually student congress, 2011 9. Best Associate editor of journal of Hepatitis Monthly, Oct 2010, 3rd international congress of Hepatitis, Tehran, Iran 8. First rank of the entrance exam of MPH for Tehran University of Medical Sciences at 2009 7. Best Student Researcher of Iran in the field of Clinical Sciences in 2009, Annual 15th Razi Festival; Tehran, Iran 6. One of the best posters of the 8th national congress of gastroenterology and hepatology with paper entitled: Estimation of hepatitis B prevalence among general population in Iran: a systematic review”, Isfahan University, Iran, November 25-28 2008 5. Honored as one of the most experienced researchers of Iran University of Medical Sciences, 2003 4. Winner of the 5th Presenter and 8th Poster at the 3rd National Medical Students' Congress, Tehran University of Medical Sciences, Iran, Dec 2002 3. Winner of the best paper award for the paper entitled as “Comparison of dermatologic patients' quality of life with healthy people” in National Medical Students' Congress, Tabriz University of Medical Sciences, Iran, May 22-25 2002, Winner of the first and 6th poster presentation at the same conference 2. Selected as one of the best Researchers of the Student Research Committee in 2001 in the Annual Seminar of the Student Research Committee, Research Office of Iran University of Medical Sciences, Student Research Committee, Iran 1. Second place for oral presentation of the paper entitled as “Evaluation of the relationship between serum free Testosterone and Gleason score of the prostatic biopsy in patients with prostate cancer” of the 2nd National Medical Students' Congress, Gholestan University of Medical Sciences, Iran, October 10-11 2001

15. Scientific Reviewer and Arbitration • Editorial Board of Hepatitis Monthly Journal: 2004-Present • Editorial Board of Developing World Epidemiology Journal: 2010 (February) – Present • Editorial Board of World Journal of Clinical Oncology: 2010 (March) – Present • Editorial Board of Journal of Tumor: 2013 (March) – Present • Editorial Board of Clinical Hepatology and Hepatitis Reports: 2014 (Jan) – Present • Editorial Board of Diabetes and the Pancreas: 2014 (July) - Present • Statistical Advisor of Journal of Global Hepatitis: 2010 (April)- Present • Reviewer of Saudi Medical Journal: 2006-Present • Reviewer of Vaccine Journal: 2007(January)-Present • Reviewer of Cancer Therapy Journal: 2007(May)-Present • Reviewer of African Journal of Biochemistry Research: 2007(July)-Present • Reviewer of Journal of Hepatology: 2008(January)-Present • Reviewer of Iranian Journal of Psychiatry and Clinical Psychology: 2009(April)-Present • Reviewer of Iranian Journal of Epidemiology: 2010(February)-Present • Reviewer of Journal of Iran University of Medical Sciences (later published as Razi Journal of Medical

Sciences): 2010(July)-Present • Reviewer of Molecular Biology Reports: 2011(Aug)-Present • Reviewer of International Journal of Preventive Medicine: 2011(Dec)-Present • Reviewer of Rehabilitation Nursing: 2012 (April)-Present • Reviewer of Journal of Gastrointestinal Cancer: 2012 (April)-Present • Reviewer of Plos One: 2012 (September)-Present

Page 13: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

13

• Reviewer of Journal of Educational Research: 2012 (September)-Present • Reviewer of Medical Principles and Practice: 2012 (September)-Present • Reviewer of Iranian Journal of Public Health: 2012 (December)-Present • Reviewer of World Journal of Gastrointestinal Surgery: 2012 (December)-Present • Reviewer of World Journal of Gastroenterology: 2013 (May)-Present • Reviewer of BMC Research Notes: 2013 (May)-Present • Reviewer of Journal of Clinical Virology: 2013 (June)-Present • Reviewer of Andrologia: 2013 (October)-Present • Reviewer of BMC Gastroenterology: 2014 (January)-Present • Reviewer of Medical Journal of the Islamic Republic of Iran: 2014 (January)-Present • Reviewer of Emergency Medicine International: 2014 (January)-Present • Reviewer of Iranian Journal of Endocrinology and Metabolism: 2014 (May)-Present • Reviewer of Iranian Journal of Psychiatry: 2014(August)-Present • Reviewer of World Journal of Hepatology: 2014(September)-Present • Reviewer of Archives of Trauma Research: 2014(September)-Present • Reviewer of International Journal of Endocrinology and Metabolism: 2014(September)-Present • Reviewer of Journal of Diabetes & Metabolic Disorders: 2014(October)-Present • Reviewer of Journal of Hepatitis Research and Treatment: 2014(October)-Present • Reviewer of Journal of Gastroenterology and Hepatology From Bed to Bench: 2014(November)-Present • Reviewer of World Journal of Anesthesiology: 2014(November)-Present • Reviewer of BMC Surgery: 2015(January)-Present • Reviewer of the scientific projects submitted to the Vice Chancellor of the research of Tehran University of

Medical Sciences, Iran University of Medical Sciences, and Shahid Beheshti University of Medical Sciences, Tehran, Iran from 2012-Present

• Consulting more than several 2500 projects and thesis for under and post- graduates

16. Personal Interests Swimming, singing, running, internet

17. Invitations, Scholarships and Grants 6. Invited for writing an Editorial for Arya Atherosclerosis journal, 2013 5. Invited author of the Word Journal of Gastroenterology, June 2013 4. Invited speaker of the symposium on methodology of research on breast cancer, Jahad, Tehran, Iran, Feb 2013 3. Invited speaker of statistical methods in medical research, Shahid Beheshti University of Medical Sciences, December 2012 2. Fellowship: Erasmus Summer Program in Epidemiology and Biostatistics, Rotterdam, Netherland: 13 Aug- 31 Aug 2012, Scholarship from NIHES (Netherlands Institute for Health Sciences) 1. Research grant, National Elite Foundation, December 2009

18. Referee 1. Reza Malekzadeh, MD, Professor of Medicine, Director of Digestive Disease Research Institute, Shariati

Hospital, Kargar Shomali Ave., 14117 Tehran University of Medical Sciences, Tehran, Iran, Deputy editor of Archives of Iranian Medicine, Email: [email protected], Tel:+9821-88026481, Fax:+9821-22253536

2. Seyed Moayed Alavian, MD, Professor of Gastroenterology and Hepatology; Dean of Research Center for Gastroenterology and Liver Disease, Baqyiatallah Hospital, Mollasadra Ave., Baqyiatallah University of Medical Sciences, Tehran, Iran; Editor-in-chief of Hepatitis Monthly, Email: [email protected],[email protected], Tel:+9821-88945186, +982181264070, Fax:+9821-88945188, PO Box 14155-3651

Page 14: Dr. Kabir ENsbmu.ac.ir/uploads/dr. kabir en.pdf · 2016. 5. 21. · Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution

14

3. Nizal Sarrafzadegan, MD, Professor of Medicine, Director of Seddigheh Tahereh Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran, E-mail: [email protected],[email protected], Tel: +98-311-3359090, 3359191, 3359292, Fax: +98-311-3373435

4. Ali Akbar Haghdoost, MD, PhD, Professor of Epidemiology, Hygiene School, Kerman University of Medical Sciences, P.O. Box: 76175-531, Kerman, Iran; Honorary senior Lecturer in London School of Hygiene and Tropical Medicine, UK, E-mails: [email protected], [email protected],[email protected], Tel: +98 341-3205091; Fax: +98-341-3205197